Immunohistochemistry Market Revenue Analysis & Region and Country Forecast To 2027

Comments · 607 Views

global Immunohistochemistry market was valued at USD 1,736.4 million in 2018 and is expected to reach USD 3,359.8 million by the year 2026

 

 

Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the immunohistochemistry industry, and increasing healthcare spending are key factors contributing to high CAGR of Immunohistochemistry market during the forecast period.

According to the current analysis of Reports and Data, The global Immunohistochemistry market was valued at USD 1,736.4 million in 2018 and is expected to reach USD 3,359.8 million by the year 2026, growing at a CAGR of 8.6%.

Immunohistochemistry (IHC) has crucial applications in the field of tissue distribution of antigens by using monoclonal and polyclonal antibodies. It is used for cancer diagnosis, because it determines the presence of tumor antigens. It is a technique which combines immunological, anatomical, and biochemical processes to identify tissue components by the interaction of target antigens with specific antibodies that are tagged by a label. Immunohistochemistry used by public and private organizations to check localization and distribution of cellular components within the cells.

Immunohistochemistry is being applied in many other areas. Immunohistochemistry is widely used to predict therapeutic response in two important tumors, i.e. carcinoma of breast and prostate. Both these tumors are under the growth regulation of the hormones estrogen and androgen, respectively. The specific receptors for these growth regulating hormones are located on respective tumor cells. Tumors expressing high level of receptor positivity would respond favorably to removal of the endogenous source of such hormones or hormonal therapy is administered to lower their levels – estrogen therapy in prostate cancer and androgen therapy in breast cancer. Immunohistochemistry techniques are also being applied to confirm infectious agent in tissues by use of specific antibodies against microbial DNA or RNA, e.g. in Cytomegalo virus, Hepatitis B virus, Hepatitis C virus, etc. The application is used routinely in validation of disease targets as it allows visualizing expression of the target in the affected tissue during the disease process. Another important advantage of Immunohistochemistry is that it can also be used to detect organisms in cytological preparations such as fluids, sputum samples, and material obtained from fine needle aspiration procedures. This can be very helpful in certain situations such as detection of pneumocystis from the sputum of an immunocompromised patient who needs rapid and precise confirmation of infection in order to begin immediate and appropriate therapy.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2198

The report puts an emphasis on the information regarding the key players with a special focus on their company profile, business overview, recent advancements, product catalog, and strategic business plans. It provides a comprehensive overview of the strategic alliances in the market under taken by the key players such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches, brand promotions, and corporate deals, among others.

Key companies operating in the market and profiled in the report include:

Abcam plc; Agilent Technologies; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; Merck KGaA; PerkinElmer, Inc.; and Thermo Fisher Scientific, Inc

Request a Order on the report @ https://www.reportsanddata.com/report-pricing/2198

The Immunohistochemistry market takes into account major geographical locations such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa to offer key insights into market growth, market size, market share, revenue growth, current and emerging trends, supply and demand ratio, import/export, consumer demand and behavior, and presence of key players in each region. The report offers an in-depth country wise analysis to impart better understanding of the market and its growth prospects.

Segments Covered in the report

Type (Revenue, USD Million; 2016–2026)

  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining Systems
    • Tissue Microarrays
    • Tissue Processing Systems
    • Slide Scanners
    • Others
  • Reagents
    • Histological Stains
    • Blocking Sera and Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

Application (Revenue, USD Million; 2016–2026)

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing

End Use (Revenue, USD Million; 2016–2026)

  • Hospitals and Diagnostic Laboratories
  • Clinics
  • Research Institutes
  • Others

Key Regions Analyzed in the Report include:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

Furthermore, it consists information about individual segment of the Immunohistochemistry  market based on the types and application. The report also offers insights about the key segments expected to register significant revenue growth over the forecast period and primary trends influencing their growth. It also offers CAGR and market share values for each segment to provide clear understanding of demand and trend in the global market.

Further key findings from the report suggest

  • Immunohistochemistry finds its application in diagnosing cancer types, chronic diseases, neurological diseases and also helps to determine the presence of benign or malignant tumor.
  • Immunohistochemistry is more advantageous than traditional enzyme staining techniqueas it involves specific antigen-antibody reactions. It is widely used in clinical diagnostics and medical research laboratories.
  • Rapid increase in healthcare spending and a changing healthcare infrastructure with better medical practice and care facilities, rise in geriatric population leads to increased need for Immunohistochemistry techniques are the driving factors of the market
  • Antibody segment accounts for largest market share of 41.2% due to rising regulatory approvals for therapeutic antibody products and is expected to show more growth during the forecast period
  • Diagnostics sub-segment dominated the Applications segment owing to a high prevalence of cancer and other such chronic diseases.
  • Hospitals sub-segment is anticipated to exhibit significant CAGR of 7.5% over the forecast period due to increasing disease prevalence and high demand for facilities with advanced infrastructure
  • The applications of Immunohistochemistry are drug testing, diagnostics amongst others. This technique plays a vital role in drug development process for testing drug efficacy through detection of up or down regulation in target diseases

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2198

Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

 

 

x

 

 

Comments